血蛋白学揭示了在整个频谱LMNA心肌病的失调路径
Usman A Tahir1,2, Daniel Reichart3, Anisha Purohit3
1Beth Israel Deaconess Medical Center, Boston, MA (U.A.T., J.L.B., G.T., L.F.).
Circulation. Genomic and precision medicine
|June 13, 2025
概括
细膜A/C (LMNA) 基因中的致病变体会导致侵袭性扩张性心肌病 (DCM). 蛋白质基因分析确定了与LMNA DCM相关的新型蛋白质和途径,有助于生物标志物发现和治疗开发.
科学领域:
- 心血管遗传学 心血管遗传学
- 蛋白质组学是指蛋白质组学.
- 分子心脏病学分子心脏病学
背景情况:
- 细膜A/C (LMNA) 基因中的致病变体与一种激烈形式的扩张性心肌病 (DCM) 有关.
- 驱动LMNA DCM进展的精确机制仍然不完全理解.
- LMNA DCM的特征是晚期导电疾病,恶性心室节律失常和心力衰竭.
研究的目的:
- 识别与致病性LMNA变体相关的蛋白质和生物通路.
- 了解LMNA DCM的分子基础.
- 探索基因型驱动治疗开发的潜在目标.
主要方法:
- 使用OLINK平台在LMNA DCM,sarcomeric DCM和对照组的队列中进行等离子体蛋白质基因分析.
- 测量了大约3000个血蛋白.
- 在晚期LMNA心力衰竭中,分析来自心肌细胞活检的单细胞RNA测序数据.
主要成果:
- 包括EDA2R和MYL4在内的几种新型蛋白质被确定与LMNADCM相关,而不是类DCM.
- 与LMNA DCM相关的26种蛋白质在心肌细胞中显示出一致的差异性基因表达.
- 通过主要成分分析识别的蛋白质组体特征与左心室喷射率和完整的心脏阻塞相关联.
结论:
- 具有致病性LMNA变异的个体的蛋白质基因分析揭示了LMNADCM中涉及的关键途径.
- 这些发现支持 LMNA DCM 的基因型驱动生物标志物发现的进步.
- 这项研究可能有助于为LMNA DCM制定量身定制的治疗策略.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
64
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64